Purple Ocean Advisory Frameworks
At Purple Ocean Advisory, we are constantly evolving and tailoring our integrated framework offering into our strategic advisory services. Our latest offerings are designed to enhance AI strategy development, lifecycle management planning, future thinking as part of your strategy development, and therapeutic area strategy. These frameworks are tailored to propel biopharmaceutical companies into the future, ensuring they remain at the forefront of innovation and market leadership.
Lifecycle Management Strategy and Planning (LMSP)
Overview
Our Lifecycle Management Strategy and Planning (LMSP) framework is designed to enhance the commercial and scientific viability of biopharmaceutical solutions throughout their lifecycle, from development to loss of exclusivity (LOE). We focus on maximizing profitability and strategic market positioning by incorporating seven key pillars with underlying exploratory questions, integrated decision trees, and inflection points.
Framework
Our comprehensive approach ensures that, during the initial launch phase, the long-term strategy and substantial investments are not overlooked but are carefully crafted to meet the diverse needs of various stakeholders across different geographies. Additionally, our framework can be applied when your solution is nearing loss of exclusivity. By anticipating and adapting to market changes, we help clients achieve sustainable long-term value both societally and financially (peak sales), effectively shaping market dynamics for sustained success.
Future Thinking Framework for Strategic Development
Overview
Our Future Thinking Framework is designed as an innovative approach to strategic planning, integrating scenario planning and forecasting to anticipate and prepare for future market conditions. This method aids organizations in navigating the uncertainties of the biopharmaceutical landscape by envisioning multiple future scenarios. This enables you to develop flexible strategies that are robust against various potential outcomes.
Framework
This strategic journey is not just about adapting to the future, but actively shaping it to align with your vision and goals. By embracing these principles, organizations can position themselves to thrive in an ever-evolving landscape. It's important to remember that this is not an exercise in predicting the future. Rather, the goal is to inform strategic decisions that will prove beneficial as you move through the next decade. Success is defined not by accurately forecasting the future, but by making strategic choices that we will value over time. As the saying goes, "All our knowledge is about the past, and all our decisions are about the future."
Therapeutic Area Strategy framework
Overview
Our Therapeutic Area Strategy framework delivers tailored solutions to deepen understanding in specific therapeutic areas. In partnership with your teams, we blend comprehensive industry knowledge with strategic insights to identify opportunities for innovation and growth within specialized fields. This collaborative approach ensures that strategies are not only scientifically sound but also aligned with the most promising opportunities.
Observation
We have observed that organizations often start with known assets or mechanisms of action (MoA) and usually focus on a limited time horizon. Our framework, however, aims to map and define the future landscape of the disease area in collaboration with your team, before shifting focus to MoA and assets.
Framework
At the core of our framework is the anticipation of future industry landscapes, which guides strategic decisions about positioning and competition. Together, we prioritize identifying and outlining emerging scientific, clinical, and medical gaps and their expected evolution. This insight is crucial for developing comprehensive disease strategies, enhancing pipelines, and crafting effective business development narratives.
Our goal is to collaboratively outline the most probable future of the disease area over your specified timeline, considering emerging needs and trends across research, clinical trials, regulatory environments, market access, development, and commercialization.
